TY - JOUR
T1 - Identification of a mouse cytoskeleton-associated protein, CKAP2, with microtubule-stabilizing properties
AU - Jin, Yi
AU - Murakumo, Yoshiki
AU - Ueno, Kaoru
AU - Hashimoto, Mizuo
AU - Watanabe, Tsuyoshi
AU - Shimoyama, Yoshie
AU - Ichihara, Masatoshi
AU - Takahashi, Masahide
PY - 2004/10
Y1 - 2004/10
N2 - Microtubule dynamics is an important factor in cell proliferation and one of the main targets of cancer chemotherapy. Since microtubule-associated proteins (MAPs) are known to influence microtubule stability, study of MAPs may contribute both to knowledge of cancer cell biology and to the production of new anti-cancer drugs. In this study, we identified a new mouse gene which is a homolog of human cytoskeleton-associated protein, CKAP2 gene, by differential display analysis. The level of expression of mouse CKAP2 (mCKAP2) was significantly higher in NIH3T3 cells expressing RET with a multiple endocrine neoplasia (MEN) 2A or MEN2B mutation than in parental NIH3T3 cells. Immunocytochemical analysis showed that mCKAP2 protein is localized in cytoplasm with a fibrillar appearance, and is co-localized with microtubules throughout the cell cycle. Furthermore, overexpression of mCKAP2 in cells appeared to stabilize microtubules against treatment with nocodazole, a microtubule-depolymerizing agent. In addition, levels of human CKAP2 were increased in some human tumor cell lines examined. These findings suggest that CKAP2 is a new MAP with microtubule-stabilizing properties and may represent a new molecular target for cancer chemotherapy.
AB - Microtubule dynamics is an important factor in cell proliferation and one of the main targets of cancer chemotherapy. Since microtubule-associated proteins (MAPs) are known to influence microtubule stability, study of MAPs may contribute both to knowledge of cancer cell biology and to the production of new anti-cancer drugs. In this study, we identified a new mouse gene which is a homolog of human cytoskeleton-associated protein, CKAP2 gene, by differential display analysis. The level of expression of mouse CKAP2 (mCKAP2) was significantly higher in NIH3T3 cells expressing RET with a multiple endocrine neoplasia (MEN) 2A or MEN2B mutation than in parental NIH3T3 cells. Immunocytochemical analysis showed that mCKAP2 protein is localized in cytoplasm with a fibrillar appearance, and is co-localized with microtubules throughout the cell cycle. Furthermore, overexpression of mCKAP2 in cells appeared to stabilize microtubules against treatment with nocodazole, a microtubule-depolymerizing agent. In addition, levels of human CKAP2 were increased in some human tumor cell lines examined. These findings suggest that CKAP2 is a new MAP with microtubule-stabilizing properties and may represent a new molecular target for cancer chemotherapy.
UR - http://www.scopus.com/inward/record.url?scp=9144230119&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=9144230119&partnerID=8YFLogxK
U2 - 10.1111/j.1349-7006.2004.tb02187.x
DO - 10.1111/j.1349-7006.2004.tb02187.x
M3 - Article
C2 - 15504249
AN - SCOPUS:9144230119
SN - 1347-9032
VL - 95
SP - 815
EP - 821
JO - Cancer science
JF - Cancer science
IS - 10
ER -
